Identifying and Accelerating the Development of Transformative Breakthrough Therapies for Patients with Severe and Rare Disorders

“Millions of patients with severe and rare diseases still suffer without meaningful treatment options. We are proceeding with an unswerving urgency to identify and advance therapeutic candidates.”

Martin Mackay, PhD, Co-Founder

Rallybio Completes $37.0M Series A Financing

Rallybio Established by Industry Leaders with $37.0 Million in Series A Financing to Develop Transformative Therapies for Patients with Severe and Rare Diseases